Viewing Study NCT03506802


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-01-25 @ 8:01 AM
Study NCT ID: NCT03506802
Status: WITHDRAWN
Last Update Posted: 2020-07-24
First Post: 2018-04-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 17-001866
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View